CORRECTED-BRIEF-Biomarin Pharmaceutical Reports Qtrly Earnings Per Share Of $0.30 (Oct.23)
October 24, 2019 at 11:57 AM EDT
* Q3 REVENUE $461.1 MILLION VERSUS REFINITIV IBES ESTIMATE OF $454.5 MILLION
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.